Cargando…

Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival

BACKGROUND: Melanoma patients with intra‐nodal nevi (INN) and without melanoma metastasis in the sentinel lymph node biopsy (SLNB) are generally treated as patients with negative SLNB. However, diagnosis of INN may be difficult and nodal melanoma metastases may falsely be regarded as INN. OBJECTIVES...

Descripción completa

Detalles Bibliográficos
Autores principales: de Beer, F.S.A., van Diest, P.J., Sigurdsson, V., El Sharouni, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899805/
https://www.ncbi.nlm.nih.gov/pubmed/31318994
http://dx.doi.org/10.1111/jdv.15814
_version_ 1783477212324823040
author de Beer, F.S.A.
van Diest, P.J.
Sigurdsson, V.
El Sharouni, M.
author_facet de Beer, F.S.A.
van Diest, P.J.
Sigurdsson, V.
El Sharouni, M.
author_sort de Beer, F.S.A.
collection PubMed
description BACKGROUND: Melanoma patients with intra‐nodal nevi (INN) and without melanoma metastasis in the sentinel lymph node biopsy (SLNB) are generally treated as patients with negative SLNB. However, diagnosis of INN may be difficult and nodal melanoma metastases may falsely be regarded as INN. OBJECTIVES: Our aim was to evaluate the clinical significance of INN in the SLNB in patients with primary cutaneous melanoma on a nationwide level in The Netherlands by comparing survival between three groups: patients with INN and without nodal melanoma metastasis (INN group), patients without INN and without nodal melanoma metastasis (negative SLNB group) and patients with nodal melanoma metastasis irrespective of INN (positive SLNB group). METHODS: Data were obtained from ‘PALGA’, the Dutch Nationwide Network and Registry of Histopathology and Cytopathology, yielding a cohort of adults with histologically proven, primary, invasive cutaneous melanoma patients in The Netherlands diagnosed between 2000 and 2014 who underwent SLNB. Clinical and pathological variables were extracted from the pathology text files. Differences between patients with INN, negative SLNB and positive SLNB were analysed using Kaplan–Meier analysis. RESULTS: A total of 11 274 patients were eligible for inclusion. The prevalence of INN in the SLNB was 5.0%. Melanomas with INN had similar median Breslow thickness compared to melanomas with negative SLNB and were more frequently located on trunk and upper limbs and observed in younger patients compared to melanomas with negative and positive SLNB. Overall survival of patients with INN showed no significant difference compared with negative SLNB (median follow‐up of 5.7 years of all patients). CONCLUSIONS: As there seems to be no difference in overall survival between patients with INN and negative SLNB, the diagnosis of INN seems to be reliable. Current practice to treat patients with INN as patients with negative SLNB appears to be appropriate.
format Online
Article
Text
id pubmed-6899805
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68998052019-12-19 Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival de Beer, F.S.A. van Diest, P.J. Sigurdsson, V. El Sharouni, M. J Eur Acad Dermatol Venereol Original Articles and Short Reports Oncology BACKGROUND: Melanoma patients with intra‐nodal nevi (INN) and without melanoma metastasis in the sentinel lymph node biopsy (SLNB) are generally treated as patients with negative SLNB. However, diagnosis of INN may be difficult and nodal melanoma metastases may falsely be regarded as INN. OBJECTIVES: Our aim was to evaluate the clinical significance of INN in the SLNB in patients with primary cutaneous melanoma on a nationwide level in The Netherlands by comparing survival between three groups: patients with INN and without nodal melanoma metastasis (INN group), patients without INN and without nodal melanoma metastasis (negative SLNB group) and patients with nodal melanoma metastasis irrespective of INN (positive SLNB group). METHODS: Data were obtained from ‘PALGA’, the Dutch Nationwide Network and Registry of Histopathology and Cytopathology, yielding a cohort of adults with histologically proven, primary, invasive cutaneous melanoma patients in The Netherlands diagnosed between 2000 and 2014 who underwent SLNB. Clinical and pathological variables were extracted from the pathology text files. Differences between patients with INN, negative SLNB and positive SLNB were analysed using Kaplan–Meier analysis. RESULTS: A total of 11 274 patients were eligible for inclusion. The prevalence of INN in the SLNB was 5.0%. Melanomas with INN had similar median Breslow thickness compared to melanomas with negative SLNB and were more frequently located on trunk and upper limbs and observed in younger patients compared to melanomas with negative and positive SLNB. Overall survival of patients with INN showed no significant difference compared with negative SLNB (median follow‐up of 5.7 years of all patients). CONCLUSIONS: As there seems to be no difference in overall survival between patients with INN and negative SLNB, the diagnosis of INN seems to be reliable. Current practice to treat patients with INN as patients with negative SLNB appears to be appropriate. John Wiley and Sons Inc. 2019-10-17 2019-12 /pmc/articles/PMC6899805/ /pubmed/31318994 http://dx.doi.org/10.1111/jdv.15814 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles and Short Reports Oncology
de Beer, F.S.A.
van Diest, P.J.
Sigurdsson, V.
El Sharouni, M.
Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title_full Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title_fullStr Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title_full_unstemmed Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title_short Intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
title_sort intra‐nodal nevi in sentinel node‐negative patients with cutaneous melanoma does not influence survival
topic Original Articles and Short Reports Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899805/
https://www.ncbi.nlm.nih.gov/pubmed/31318994
http://dx.doi.org/10.1111/jdv.15814
work_keys_str_mv AT debeerfsa intranodalneviinsentinelnodenegativepatientswithcutaneousmelanomadoesnotinfluencesurvival
AT vandiestpj intranodalneviinsentinelnodenegativepatientswithcutaneousmelanomadoesnotinfluencesurvival
AT sigurdssonv intranodalneviinsentinelnodenegativepatientswithcutaneousmelanomadoesnotinfluencesurvival
AT elsharounim intranodalneviinsentinelnodenegativepatientswithcutaneousmelanomadoesnotinfluencesurvival